An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
Figure 2
Beneficial effects of GLP-1 in other cells exposed to AGEs. Detrimental effect of AGEs leads to cell dysfunction and, eventually, cell death. GLP-1, counteracting AGEs-induced damage with mechanisms reported in pancreatic beta cells, may contribute to reducing diabetic complications.